Article

Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities

2023-02-16

Abstract excerpt

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has necessitated the global development of countermeasures since its outbreak. However, current therapeutics and vaccines to stop the pandemic are insufficient and this is mainly because of the emergence of resistant variants, which requires the urgent development of new countermeasures, such a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4502bc92-db17-5c69-901b-f02015f76d79
DOI: 10.1101/2023.02.15.528742

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilitiesDOI 10.1101/2023.02.15.528742Read

Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testingSemantic proximity Read

Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.Semantic proximity Read

Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function StudiesSemantic proximity Read

SARS-CoV-2 replicon for high-throughput antiviral screeningSemantic proximity Read

Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replicationSemantic proximity Read

Construction and characterization of two SARS‐CoV‐2 minigenome replicon systemsSemantic proximity Read

Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screeningSemantic proximity Read

Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug ScreenSemantic proximity Read

Reverse genetics systems for SARS‐CoV‐2Semantic proximity Read

SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay SystemSemantic proximity Read

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testingSemantic proximity Read

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19Semantic proximity Read